Fenwick represented Cadence Neuroscience on the deal. Cadence Neuroscience, a medical device company, announced that it has secured $26 million in Series B financing. The round was led by...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here